Carcinoma in situ of oral cavity

CD2_INSITU_ORALCAVITY_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

  • not C3_ORALCAVITY
-

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 C0[1-6]
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 2

1 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF12
Parent code in ICD-10
D00-D09
Name in latin
Carcinoma in situ labii (oris)

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 206 81 124
Only index persons 184 77 107
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population 67.27 69.00 66.20
Only index persons 66.06 66.10 66.03

-FinnGen-

Key figures

All Female Male
Number of individuals 74 26 48
Unadjusted period prevalence (%) 0.02 0.01 0.02
Median age at first event (years) 68.07 70.39 66.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
65
Matched controls
649
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
150.0
27.1
27
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
48.7
15.4
18
5
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
+∞
15.2
14
*
K13.29
ICD-10 Finland
Indefinite leukoplakia
+∞
12.9
12
*
130
Kela drug reimbursment
Malignant tumour
+∞
12.9
12
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
27.2
11.3
15
7
D00.00
ICD-10 Finland
Cancer in situ on the lip red border
+∞
10.7
10
*
8070/2-C00.1
ICD-O-3
Squamous cell carcinoma in situ, NOS, of external lower lip
+∞
9.6
9
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
9.6
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.9
9.2
30
82
H02AB02
ATC
dexamethasone; systemic
58.1
8.9
10
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
24.0
8.8
12
6
K13.78
ICD-10 Finland
Other change in the oral mucosa
26.0
8.3
11
5
EP1AE
NOMESCO Finland
Neck ultrasound examination
15.9
8.3
13
10
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
7.4
7
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.1
7.2
16
25
WX110
NOMESCO Finland
Local anesthesy
4.5
6.7
52
304
WX402
NOMESCO Finland
General anaesthesia
6.0
6.4
18
39
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
29.9
6.4
8
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
29.9
6.4
8
*
L57.0
ICD-10 Finland
Actinic keratosis
6.7
6.4
16
30
D00.05
ICD-10 Finland
In situ cancer of the pharyngeal part of the tongue
+∞
6.3
6
*
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
+∞
6.3
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
22
27
11.17
17.62
1.6
1.1
—
—
—
0
0
15
17
10.81
12.45
1.7
1.2
—
—
—
0
0
42
144
5.43
12.03
3.5
1.5
—
—
—
0
0
16
40
4.83
6.27
1.3
1.7
0.2
0.2
g/l
0.94
16
33
16
42
4.58
5.90
10.7
6.1
—
—
—
0
0
33
151
3.14
5.37
3.9
2.1
—
—
—
0
0
29
136
2.86
4.37
3.1
2.3
—
—
—
0
0
30
147
2.75
4.13
3.1
2.4
1.4
0.6
e6/l
0.61
19
99
10
24
4.66
4.03
11.8
5.9
—
—
—
0
0
31
159
2.63
3.86
3.4
2.6
84.9
468.6
e6/l
0.41
20
112
11
31
3.99
3.64
13.5
4.5
0.7
0.8
%
0.14
11
31
33
188
2.36
3.17
3.7
3.2
75.9
53.9
e6/l
0.16
21
124
10
31
3.57
2.89
14.7
4.5
0.9
1.6
%
—
10
31
5
6
8.82
2.79
1.4
2.3
9.5
14.2
%
—
5
6
15
65
2.64
2.51
2.1
1.6
—
—
—
0
0
9
201
0.37
2.31
4.1
3.1
—
—
—
0
0
37
246
2.01
2.24
6.9
9.4
1.6
1.3
inr
—
8
67
7
20
3.75
2.11
1.4
2.0
—
—
—
0
0
29
183
1.96
1.98
5.2
5.1
—
—
—
0
0
13
59
2.46
1.98
1.5
1.7
—
—
—
0
0
5
11
4.79
1.97
6.0
1.3
—
—
—
0
0
21
119
2.07
1.92
1.3
1.7
1452.9
1216.3
nmol/l
0.41
14
89
5
12
4.38
1.85
1.8
2.7
50.6
64.4
%
—
5
12
6
19
3.34
1.70
1.5
3.5
—
—
—
0
0
25
159
1.86
1.63
10.0
3.2
—
—
—
0
0
11
51
2.36
1.60
1.3
1.4
—
—
—
0
0
65
569
2.17
1.55
25.5
13.0
40.1
23.1
mg/l
1.95
55
453
5
15
3.49
1.55
1.8
3.4
—
—
—
0
0
9
39
2.48
1.49
9.7
3.9
24.0
24.5
mmol/l
—
9
39
12
62
2.12
1.37
2.5
4.1
—
—
—
0
0
21
133
1.81
1.37
1.6
1.3
—
—
—
0
0
10
48
2.25
1.35
1.4
1.7
—
—
—
0
0
8
34
2.51
1.34
2.0
2.7
0.6
0.6
%
—
8
34
8
35
2.44
1.31
2.0
2.6
1.7
1.4
%
—
8
35
33
243
1.65
1.25
1.9
2.0
98.1
94.9
pmol/l
0.14
14
119
32
237
1.62
1.17
7.5
8.6
0.0
0.0
e9/l
0.00
25
197
36
276
1.59
1.13
6.0
5.1
0.6
0.6
e9/l
0.50
30
234
19
125
1.70
1.08
7.7
5.1
—
—
—
0
0
36
279
1.57
1.07
6.0
5.1
0.0
0.0
e9/l
0.66
30
239
7
34
2.17
1.06
1.3
1.5
—
—
—
0
0
65
589
1.85
1.03
18.2
12.4
—
—
—
0
0
23
162
1.61
1.01
4.0
2.7
—
—
—
0
0
36
282
1.54
1.00
6.1
5.1
1.6
1.8
e9/l
1.59
31
245
44
363
1.52
0.95
4.5
4.1
—
—
—
0
0
65
594
1.77
0.91
29.8
15.6
86.4
84.9
umol/l
0.09
65
594
8
48
1.75
0.82
1.3
1.3
—
—
—
0
0
0
25
0.00
0.80
0.0
1.2
—
—
—
0
0
10
157
0.58
0.80
2.8
2.0
370.0
9891.9
umol/l
—
10
136
56
496
1.53
0.78
31.9
14.1
35.4
40.7
%
1.95
38
325
37
304
1.43
0.76
12.2
6.2
4.3
4.3
e9/l
0.01
32
261
51
447
1.45
0.72
32.5
16.0
13.9
13.8
%
0.09
51
437
7
42
1.73
0.70
6.0
1.3
—
—
—
0
0
7
42
1.73
0.70
2.1
2.3
—
—
—
0
0
24
184
1.45
0.70
3.7
3.3
44.6
421.1
mg/l
0.57
18
120
7
43
1.69
0.69
1.6
1.3
—
—
—
0
0
8
49
1.71
0.65
1.4
1.5
—
—
—
0
0
7
111
0.59
0.64
5.1
4.7
—
—
—
0
0
10
148
0.63
0.63
3.2
3.2
—
—
—
0
0
24
189
1.40
0.60
3.5
3.0
5.1
7.6
mmol/l
5.00
19
150
14
188
0.69
0.56
4.8
4.1
—
—
—
0
0
9
62
1.51
0.56
2.2
2.1
—
—
—
0
0
45
396
1.35
0.55
4.1
3.8
—
—
—
0
0
47
418
1.34
0.53
3.6
3.5
15.0
15.0
pmol/l
0.05
42
375
12
87
1.45
0.45
4.0
1.6
—
—
—
0
0
59
549
1.37
0.44
7.2
6.6
41.8
41.0
mmol/mol
0.21
53
508
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
24
201
1.29
0.39
4.2
3.8
7.7
11.4
mg/mmol
0.36
16
124
16
127
1.33
0.37
2.3
3.2
—
—
—
0
0
7
52
1.38
0.32
12.0
3.0
—
—
—
0
0
52
548
0.83
0.24
4.5
4.2
1.6
1.3
mmol/l
0.87
45
494
5
39
1.30
0.23
1.2
1.5
—
—
—
0
0
5
40
1.27
0.23
1.8
3.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
54
563
0.85
0.19
4.8
4.7
1.5
1.4
mmol/l
0.31
46
512
6
75
0.78
0.16
1.3
1.2
—
—
—
0
0
55
568
0.88
0.13
4.6
4.7
4.3
4.5
mmol/l
0.87
48
522
57
583
0.90
0.08
5.4
5.3
2.3
2.6
mmol/l
2.65
51
527
28
270
1.06
0.04
3.2
4.0
28.0
54.7
ng/l
1.28
19
211
20
204
0.97
0.00
2.9
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
5.1
—
67.1
—
0
7
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
3.5
—
338.0
—
0
8
0
5
0.00
0.00
0.0
1.2
—
1.7
—
0
5
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
11.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
6.5
—
0
5
0
7
0.00
0.00
0.0
3.1
—
34.9
—
0
7
0
7
0.00
0.00
0.0
1.1
—
297.3
—
0
7
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
7.6
—
0
6

Mortality – FinRegistry

Association

Association between endpoint CD2_INSITU_ORALCAVITY_EXALLC and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_INSITU_ORALCAVITY_EXALLC.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: CD2_INSITU_ORALCAVITY_EXALLC – Carcinoma in situ of oral cavity

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data